EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication

Moe Kobayashi, Hatsumi Abe, Hikaruko Sugihara, Nene Kobayashi, Seira Omori, Yasuhiro Yamada, Takeshi Ichinohe iD

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Moe Kobayashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Sc…. Hauptthemen laut MEDLINE: TRPV Cation Channels, Virus Replication, SARS-CoV-2, Calcium. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Shionogi Infectious Disease Research Promotion Foundation, NOVARTIS Foundation (Japan) for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temperature varies across the nasal cavity, lower respiratory tract, and during febrile conditions, yet the impact of these differences on SARS-CoV-2 replication remains poorly understood. Here, we show that ancestral SARS-CoV-2, Delta, or Omicron BA.5 variants replicate most efficiently at 37°C. We found that transient receptor potential vanilloid 4 (TRPV4)-mediated calcium influx, a thermosensitive cation channel known to be activated at 37°C, contributes to efficient SARS-CoV-2 replication. In addition, a calcineurin inhibitor, cyclosporine A (Cys A), and manidipine, an FDA-approved calcium channel blocker, both suppressed viral replication and protected Syrian hamsters from lethal infection with the SARS-CoV-2 Delta variant. Notably, a selective TRPV4 antagonist also conferred protection in infected hamsters. These results suggest that TRPV4-mediated calcium influx contributes to efficient SARS-CoV-2 replication at 37°C and highlight manidipine as a strong candidate for repurposing as an anti-SARS-CoV-2 therapeutic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsVirus ReplicationSARS-CoV-2CalciumAnimalsCricetinaeHumansMesocricetusCOVID-19TemperatureChlorocebus aethiopsVero CellsCalcium Channel BlockersCyclosporine

Substanzen

TRPV Cation ChannelsCalciumTRPV4 protein, humanCalcium Channel BlockersCyclosporine

Autor:innen und Institutionen

  • Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Molecular Pathology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Takeshi Ichinohe

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • Shionogi Infectious Disease Research Promotion Foundation
  • NOVARTIS Foundation (Japan) for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Kobayashi, M., Abe, H., Sugihara, H., Kobayashi, N., Omori, S., Yamada, Y., & Ichinohe, T. (2026). TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014520

Vancouver

Kobayashi M, Abe H, Sugihara H, Kobayashi N, Omori S, Yamada Y, et al. TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014520

BibTeX
@article{Kobayashi2026,
  author = {Kobayashi, Moe and Abe, Hatsumi and Sugihara, Hikaruko and Kobayashi, Nene and Omori, Seira and Yamada, Yasuhiro and Ichinohe, Takeshi},
  title = {TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014520}
}
Kostenlos starten →